Oxford Drug Design (Inhibox) Revenue and Competitors
Estimated Revenue & Valuation
- Oxford Drug Design (Inhibox)'s estimated annual revenue is currently $1.2M per year.
- Oxford Drug Design (Inhibox)'s estimated revenue per employee is $78,000
Employee Data
- Oxford Drug Design (Inhibox) has 15 Employees.
- Oxford Drug Design (Inhibox) grew their employee count by 50% last year.
Oxford Drug Design (Inhibox)'s People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head ML and methods development | Reveal Email/Phone |
3 | Head ML & Methods Development | Reveal Email/Phone |
4 | Head Biology | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Senior Computational Chemist | Reveal Email/Phone |
7 | Early stage researcher | Reveal Email/Phone |
Oxford Drug Design (Inhibox) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is Oxford Drug Design (Inhibox)?
Oxford Drug Design develops and applies novel and effective computational methods to improve the productivity of drug discovery. The ODD discovery pipeline focuses on the delivery of novel antibiotics for the treatment of drug-resistant bacterial infections.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.2M | 15 | 50% | N/A |
#2 | $2.4M | 15 | N/A | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $1.3M | 15 | N/A | N/A |
#5 | $4M | 16 | 7% | N/A |